Skip to main content
Cureus logoLink to Cureus
. 2021 Feb 28;13(2):e13605. doi: 10.7759/cureus.13605

Transcranial Dopplers Revisited: Development of Novel Markers for Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage

Rocco Dabecco 1, Michael J Gigliotti 2, Gordon Mao 1,, Sarah Browning 3, Steven Hertz 4, Sungyub Lew 5
Editors: Alexander Muacevic, John R Adler
PMCID: PMC8011464  PMID: 33816004

Abstract

Background

Cerebral vasospasm has been monitored by conventional angiography or transcranial Doppler (TCD). While angiography is the most accurate and reliable method for detection, TCDs are a noninvasive alternative to monitor onset and resolution of vasospasm. We aim to determine whether alternative TCD parameters rather than Lindegaard ratio lead to an improved method to diagnose and potentially prevent cerebral vasospasm.

Methods

A total of 103 consecutive patients with subarachnoid hemorrhage (SAH) were retrospectively reviewed and TCD studies were performed during the first 14 days post-bleed or longer if indicated. Multivariate logistic regression models were developed using significant univariate characteristics. Receiver operating characteristic (ROC) curves evaluated the mean middle cerebral artery (MCA), peak systolic MCA (PSV MCA), and end diastolic MCA (EDV MCA) velocities as well as ratios when compared to the ipsilateral extracranial internal carotid artery (ICA). The area under the curve was calculated to compare accuracy for symptomatic vasospasm.

Results

Thirteen patients (12.6%) were observed to develop cerebral vasospasm. Aneurysm location (p = 0.51), Hunt and Hess grade (p = 0.44), Fischer grade (p = 0.87), comorbidities, age (p = 0.67), or gender (p = 0.41) did not appear to have any effect in predicting the presence of vasospasm. ROC curves demonstrated that MCA EDV appeared to be slightly better compared to MCA velocity in predicting symptomatic vasospasm. PSV MCA/extracranial ICA and the EDV MCA/extracranial ICA ratios appeared to be an improvement to the Lindegaard ratio in the prediction of symptomatic vasospasm.

Conclusion

The utility of peak systolic and end diastolic velocities, instead of the classically referenced mean velocities and Lindegaard ratio, may improve diagnostic sensitivity of cerebral vasospasm after subarachnoid hemorrhage.

Keywords: transcranial doppler, subarachnoid hemorrhage, aneurysm, vasospasm

Introduction

Cerebral vasospasm is a major cause of morbidity and death after aneurysmal subarachnoid hemorrhage (SAH) [1]. The peak frequency of cerebral vasospasm is from three to 14 days after SAH [2]. Twenty-eight percent of patients with SAH suffer clinical deterioration due to ischemic events caused by vasospasm. Of that twenty-eight percent, fifty percent of those patients either suffer long-term morbidity or they die due to delayed cerebral ischemia (DCI) [1-3]. Conventional angiography is the most accurate and reliable method for detection of vasospasm. However, it is invasive and is not without risk.

In 1982, transcranial Doppler (TCD) ultrasound was introduced by Aaslid [4] as a way to monitor the cerebral vasculature for onset and resolution of vasospasm in a noninvasive manner. There have been several studies that have attempted to correlate vasospasm with an increase in TCD velocities of the cerebral vasculature since its inception, however, the value of these studies remains controversial [3,4-7]. Despite mixed results, TCD remains the most widely used imaging modality for diagnosing cerebral vasospasm [1]. The purpose of our retrospective analysis was to evaluate alternative TCD parameters other than the classically utilized mean middle cerebral artery (MCA) velocity and mean MCA/extracranial internal carotid artery (ICA) ratio (Lindegaard ratio). The above data, when combined and analyzed along with specific clinical characteristics which may be associated with an increased risk of vasospasm, may lead to an improved method to diagnose and even prevent symptomatic vasospasm.

Materials and methods

Patient population and demographics

A retrospective review and analysis of electronic medical records, radiographic studies, and angiographic studies was completed on 103 consecutive patients who were admitted to our institution for the treatment of spontaneous subarachnoid hemorrhage (SAH) between September 2010 and March 2015. The review of the above clinical data was performed in accordance with our institutional review board regulations (IRB Study Number 15-26, Saint Barnabas Medical Center). The diagnosis of SAH was established by CT scan or by blood or xanthochromia in the cerebrospinal fluid (CSF). Patients were excluded if they were less than 18 years of age, had poor cranial TCD windows preventing accurate analysis, and SAH caused by trauma, arteriovenous malformation, mycotic aneurysm rupture, vasculitis, or other secondary causes.

Clinical characteristics

Clinical characteristics that were analyzed included age, sex, Hunt and Hess grade, Fischer grade, time at which vasospasm occurred after SAH, day of treatment, type of treatment, and medical comorbidities (i.e., hypertension history, diabetes history, hyperlipidemia history, smoking history, and illicit drug use history). The diagnosis of symptomatic vasospasm was made as a diagnosis of exclusion, based on the development of global or focal neurological deterioration that was not explained by other causes. No retrospective diagnosis of symptomatic vasospasm was made.

Transcranial Doppler evaluation

The TCD studies were performed three days per week (Monday, Wednesday, and Friday) during the initial post-bleed course (post-bleed day 0-14). Some patients continued to undergo TCD evaluation after the typical 14-day monitoring period due to evidence of vasospasm, radiographic and/or clinical evidence of vasospasm, or due to poor clinical status and continued stay in our intensive care unit (ICU). Velocities of both the anterior and posterior circulations were measured bilaterally through the transtemporal and suboccipital windows using a 2-MHz handheld pulse-wave probe (Sonara TCD System, Natus Medical Incorporated, Middletown, WI).

Statistical analysis

Analysis was performed using IBM SPSS Statistics software, version 22 (IBM Corporation, Armonk, New York). Univariate analysis was performed on the clinical characteristics listed in Table 1. A multivariate logistic regression model was then designed using the significant univariate characteristics. Receiving operating characteristic (ROC) curves were constructed to evaluate the mean, peak systolic, and end diastolic MCA velocities and the ratios of those values when compared to the ipsilateral external internal carotid artery (ICA). The areas under the curves were then calculated to compare the accuracy of the different velocities in the detection of symptomatic vasospasm.

Table 1. Patient demographics presenting with subarachnoid hemorrhage (with or without cerebral vasospasm).

EDV: End diastolic velocity; ACOMM: Anterior communicating artery; ICA: Internal carotid artery; MCA: Middle cerebral artery.

  Overall No vasospasm Vasospasm p-value
Age 57 (14.1%) 57 (14.4%) 56 (12.3%) 0.669
Gender        
          Male 27 (0.2%) 25 (0.3%) 2 (0.2%) 0.405
          Female 76 (0.7%) 65 (0.7%) 11 (0.8%)
Comorbidity        
          Hypertension 61 (0.6%) 54 (0.6%) 7 (0.5%) 0.981
          Diabetes 20 (0.2%) 17 (0.2%) 3 (0.2%) 0.863
          Hyperlipidemia 32 (0.3%) 28 (0.3%) 4 (0.3%) 0.969
Drug Use 5 (0%) 4 (0%) 1 (0.1%) 0.827
Smoker 42 (0.4%) 37 (0.4%) 5 (0.4%) 0.982
Family History 2 (0%) 2 (0%) 0 (0%) 0.861
EDV 61 (0.6%) 50 (0.5%) 11 (0.8%) 0.082
Mortality 20 (0.2%) 18 (0.2%) 2 (0.2%) 0.651
Hunt & Hess grade 0.442
          1 22 (0.2%) 21 (0.2%) 1 (0.1%)
          2 28 (0.3%) 24 (0.3%) 4 (0.3%)
          3 26 (0.3%) 21 (0.2%) 5 (0.4%)
          4 10 (0.1%) 8 (0.1%) 2 (0.2%)
          5 18 (0.2%) 17 (0.2%) 1 (0.1%)
Fischer grade 0.873
          1 4 (0%) 4 (0%) 0 (0%)
          2 17 (0.2%) 15 (0.2%) 2 (0.2%)
          3 25 (0.2%) 22 (0.2%) 3 (0.2%)
          4 57 (0.6%) 49 (0.5%) 8 (0.6%)
Location 0.514
          ACOMM 22 (0.2%) 3 (0.2%) 25 (0.2%)
          ICA 8 (0.1%) 2 (0.2%) 10 (0.1%)
          MCA 12 (0.1%) 3 (0.2%) 15 (0.1%)
          Posterior circulation 18 (0.2%) 3 (0.2%) 21 (0.2%)
          Other 36 (0.4%) 2 (0.2%) 38 (0.3%)

Results

A retrospective review of 103 consecutive patients presenting to our institution with SAH was completed. Of these patients, 76 were female (74%) and 27 were male (26%) with an age range of 25 to 89 (mean = 57). Vasospasm was observed in 13 patients (12.6%) compared to 90 patients (87.4%) without cerebral vasospasm. The most common post-bleed day in which symptomatic, cerebral vasospasm was detected was day 7 (Figure 1) and the most common Hunt and Hess grade at which vasospasm occurred was grade 3 (Figure 2).

Figure 1. Distribution of patients developing symptomatic vasospasm according to day number post-subarachnoid hemorrhage.

Figure 1

Figure 2. Distribution of patients developing vasospasm according to Hunt and Hess Grade.

Figure 2

Anterior communicating artery (ACOMM) aneurysms and hypertension represented the most common aneurysm and comorbidity associated with vasospasm, respectively. There did not appear to be a statistically significant increased risk of detection of cerebral vasospasm based on location of the aneurysm (p = 0.51), Hunt and Hess grade (p = 0.44), Fischer grade (p = 0.87), comorbidities, age (p = 0.67), or gender (p = 0.41). A complete, univariate analysis of patient demographic information is in Table 1. Multivariate analysis yielded two ROC curves (Figures 3-4).

Figure 3. Receiver operating characteristic (ROC) curve demonstrating slight MCA EDV improvement (0.686, 95% CI: 0.562 – 0.811) to MCA mean velocity (0.684; 95% CI: 0.562 – 0.806) to predict symptomatic velocity.

Figure 3

MCA: Middle cerebral artery; EDV: End diastolic velocity.

Figure 4. Receiver operating characteristic (ROC) curve demonstrating PSV MCA/extracranial ICA (0.654; 95% CI: 0.526 – 0.783) and the EDV MCA/extracranial ICA (0.644; 95% CI: 0.514 – 0.773) ratios appear to be better at predicting symptomatic vasospasm compared to the classically utilized Mean MCA/extracranial ICA ratio (0.621; 95% CI: 0.490 – 0.752).

Figure 4

MCA: Middle cerebral artery; ICA: Internal carotid artery; PSV: Peak systolic velocity.

Figure 3 demonstrated that MCA EDV (0.686; 95% CI: 0.562 - 0.811) was slightly improved when compared to MCA mean velocity (0.684; 95% CI: 0.562 - 0.806) in the prediction of symptomatic vasospasm. Alternatively, Figure 4 demonstrated that PSV MCA/extracranial ICA (0.654; 95% CI: 0.526 - 0.783) and the EDV MCA/extracranial ICA (0.644; 95% CI: 0.514 - 0.773) ratio showed an improvement to predicting symptomatic vasospasm compared to the Lindegaard ratio (0.621; 95% CI: 0.490 - 0.752).

Discussion

Symptomatic vasospasm remains the major cause of morbidity and mortality in patients with SAH. The goal of TCD monitoring is to identify patients at risk for vasospasm, enabling prompt and effective treatment of these patients. Suarez et al. were able to demonstrate that TCD velocities can be utilized to identify vasospasm at a mean of 24 hours before the presence of symptomatic vasospasm, showing that there is predictive power in this tool as well [8]. The studies typically referenced in the literature use the mean velocities for analyzing the risk of vasospasm. In our study, we aimed to evaluate the accuracy of non-traditional intracranial blood flow parameters against the historical benchmarks of the mean MCA velocity and Lindegaard ratio in predicting significant vasospasm after aneurysm rupture.

Our multivariate analysis eventually identified the MCA EDV and MCA PSV/extracranial ICA as new candidates for predictors of DCI and symptomatic vasospasm. Using the ROC, we saw that the accuracy (ROC area underneath the curve) was improved for MCA EDV (0.686) compared to the MCA mean (0.684) and the MCA PSV/extracranial ICA (0.654) as well as MCA EDV/extracranial ICA (0.644) versus the mean MCA/extracranial ICA (0.621). However, the 95% CI demonstrated overlap between these new candidate measures and the traditional mean MCA and Lindegaard ratio indicating a trend toward significance. Future analysis to determine whether these alternative means to predicting intracranial vasospasm are in fact an improvement over traditional measures should include more data points as more patients undergo TCD monitoring for SAH.

Another area that we would like to concentrate on with further analysis is examining the percentage change in velocities both from a baseline value (the initial TCD study) and on a day-to-day basis. We would like to take that possible predictive value demonstrated in prior studies one step further, ultimately analyzing possible threshold values or cut-off points that determine the risk of vasospasm for patients with SAH. This analysis may be similar to Malhotra et al., who demonstrated that an absolute increase by >50 cm/second over the course of 48 hours was significant in predicting vasospasm [9]. However, percent changes from baseline and day-to-day percentage changes were poor predictors.

Conclusions

Reviewing and analyzing five years of clinical, angiographic, radiographic, and TCD data has shown us that utilizing the peak systolic and end diastolic velocities, instead of the classically referenced mean velocities and Lindegaard ratio, may improve the diagnosis of cerebral vasospasm after subarachnoid hemorrhage. As we continue to add new patients in our database, we anticipate that the power of our study will continue to increase to better support the diagnostic superiority of our current study variables over the traditional measures. Moreover, future directions should be dedicated to evaluating the possibility of accurately predicting vasospasm, prior to the onset of clinical symptoms, utilizing the change in velocity from the patient’s baseline TCD as a comparison.

The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.

The authors have declared that no competing interests exist.

Human Ethics

Consent was obtained or waived by all participants in this study. Saint Barnabas Medical Center issued approval Study Number 15-26

Animal Ethics

Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.

References

  • 1.Transcranial Doppler for predicting delayed cerebral ischemia after subarachnoid hemorrhage. Carrera E, Schmidt JM, Oddo M, et al. Neurosurgery. 2009;65:316–323. doi: 10.1227/01.NEU.0000349209.69973.88. [DOI] [PubMed] [Google Scholar]
  • 2.Transcranial Doppler ultrasonography for diagnosis of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: mean blood flow velocity ratio of the ipsilateral and contralateral middle cerebral arteries. Nakae R, Yokota H, Yoshida D, Teramoto A. Neurosurgery. 2011;69:876–883. doi: 10.1227/NEU.0b013e318222dc4c. [DOI] [PubMed] [Google Scholar]
  • 3.Vasospasm probability index: a combination of transcranial doppler velocities, cerebral blood flow, and clinical risk factors to predict cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Gonzalez NR, Boscardin WJ, Glenn T, Vinuela F, Martin NA. J Neurosurg. 2007;107:1101–1112. doi: 10.3171/JNS-07/12/1101. [DOI] [PubMed] [Google Scholar]
  • 4.Transcranial Doppler assessment of cerebral vasospasm. Aaslid R. Eur J Ultrasound. 2002;16:3–10. doi: 10.1016/s0929-8266(02)00045-9. [DOI] [PubMed] [Google Scholar]
  • 5.Prediction of delayed cerebral ischemia after subarachnoid hemorrhage using cerebral blood flow velocities and cerebral autoregulation assessment. Calviere L, Nasr N, Arnaud C, et al. Neurocrit Care. 2015;23:253–258. doi: 10.1007/s12028-015-0125-x. [DOI] [PubMed] [Google Scholar]
  • 6.Vasospasm diagnosis: theoretical and real transcranial Doppler sensitivity. Creissard P, Proust F, Langlois O. Acta Neurochir (Wien) 1995;136:181–185. doi: 10.1007/BF01410623. [DOI] [PubMed] [Google Scholar]
  • 7.Vasospasm on transcranial Doppler is predictive of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Kumar G, Shahripour RB, Harrigan MR. J Neurosurg. 2016;124:1257–1264. doi: 10.3171/2015.4.JNS15428. [DOI] [PubMed] [Google Scholar]
  • 8.Symptomatic vasospasm diagnosis after subarachnoid hemorrhage: evaluation of transcranial Doppler ultrasound and cerebral angiography as related to compromised vascular distribution. Suarez JI, Qureshi AI, Yahia AB, et al. https://pubmed.ncbi.nlm.nih.gov/12072693/ Crit Care Med. 2002;30:1348–1355. doi: 10.1097/00003246-200206000-00035. [DOI] [PubMed] [Google Scholar]
  • 9.Relative changes in transcranial Doppler velocities are inferior to absolute thresholds in prediction of symptomatic vasospasm after subarachnoid hemorrhage. Malhotra K, Conners JJ, Lee VH, Prabhakaran S. J Stroke Cerebrovasc Dis. 2014;23:31–36. doi: 10.1016/j.jstrokecerebrovasdis.2012.08.004. [DOI] [PubMed] [Google Scholar]

Articles from Cureus are provided here courtesy of Cureus Inc.

RESOURCES